Analysis of 1-Year Clinical Outcomes in the SIRIUS Trial

Abstract
Background— This study evaluated a large group of patients enrolled in a double-blind randomized trial of the sirolimus-eluting stent to document whether the initial clinical improvement seen in previous smaller series is maintained out to 12 months and to study the potential treatment effect in patient subsets known to be at increased risk of restenosis.

This publication has 16 references indexed in Scilit: